On the contrary, HER2+ tumor cells are modified upon interaction with activated fibroblasts, but those changes do not seem to affect prognosis in women with HER2+ tumors, suggesting that the tumor‐intrinsic features play a major role compared to the microenvironment. Here, ERBB2 is linked to neoplasm.